Selected research
Industry Research
Inactivated Probiotics Industry Research Report 2026
Market perspective
The global Inactivated Probiotics market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Inactivated Probiotics is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Inactivated Probiotics is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Inactivated Probiotics is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Inactivated Probiotics include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Inactivated Probiotics market in revenue (US$ million) and, where applicable, sales volume (kt), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/kt) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Inactivated Probiotics.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Inactivated Probiotics Market by Company
IFF
Huanyi
Scitop
GenMont Biotech
Harbin Qiutianhong Health Technology Group
Probioway
Lesaffre
Lallemand Health Solutions
Glac Biotech
Creative Biolabs
Chr. Hansen
Wecare Probiotics
Inactivated Probiotics Segment by Type
Radiation Inactivation
Ultrasound Inactivation
Heat Inactivation
Others
Inactivated Probiotics Segment by Application
Food and Beverages
Medicine and Health Products
Inactivated Probiotics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inactivated Probiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Inactivated Probiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inactivated Probiotics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Inactivated Probiotics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Inactivated Probiotics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Inactivated Probiotics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Radiation Inactivation
- Ultrasound Inactivation
- Heat Inactivation
- Others
Applications
- Food and Beverages
- Medicine and Health Products
Companies covered
- IFF
- Huanyi
- Scitop
- GenMont Biotech
- Harbin Qiutianhong Health Technology Group
- Probioway
- Lesaffre
- Lallemand Health Solutions
- Glac Biotech
- Creative Biolabs
- Chr. Hansen
- Wecare Probiotics
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Inactivated Probiotics by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Radiation Inactivation
- 2.2.3 Ultrasound Inactivation
- 2.2.4 Heat Inactivation
- 2.2.5 Others
- 2.3 Inactivated Probiotics by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Food and Beverages
- 2.3.3 Medicine and Health Products
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Inactivated Probiotics Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Inactivated Probiotics Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Inactivated Probiotics Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Inactivated Probiotics Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Inactivated Probiotics Production by Manufacturers (2021-2026)
- 3.2 Global Inactivated Probiotics Production Value by Manufacturers (2021-2026)
- 3.3 Global Inactivated Probiotics Average Price by Manufacturers (2021-2026)
- 3.4 Global Inactivated Probiotics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Inactivated Probiotics Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Inactivated Probiotics Manufacturers, Product Type & Application
- 3.7 Global Inactivated Probiotics Manufacturers Established Date
- 3.8 Global Inactivated Probiotics Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 IFF
- 4.1.1 IFF Inactivated Probiotics Company Information
- 4.1.2 IFF Inactivated Probiotics Business Overview
- 4.1.3 IFF Inactivated Probiotics Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 IFF Product Portfolio
- 4.1.5 IFF Recent Developments
- 4.2 Huanyi
- 4.2.1 Huanyi Inactivated Probiotics Company Information
- 4.2.2 Huanyi Inactivated Probiotics Business Overview
- 4.2.3 Huanyi Inactivated Probiotics Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Huanyi Product Portfolio
- 4.2.5 Huanyi Recent Developments
- 4.3 Scitop
- 4.3.1 Scitop Inactivated Probiotics Company Information
- 4.3.2 Scitop Inactivated Probiotics Business Overview
- 4.3.3 Scitop Inactivated Probiotics Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Scitop Product Portfolio
- 4.3.5 Scitop Recent Developments
- 4.4 GenMont Biotech
- 4.4.1 GenMont Biotech Inactivated Probiotics Company Information
- 4.4.2 GenMont Biotech Inactivated Probiotics Business Overview
- 4.4.3 GenMont Biotech Inactivated Probiotics Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 GenMont Biotech Product Portfolio
- 4.4.5 GenMont Biotech Recent Developments
- 4.5 Harbin Qiutianhong Health Technology Group
- 4.5.1 Harbin Qiutianhong Health Technology Group Inactivated Probiotics Company Information
- 4.5.2 Harbin Qiutianhong Health Technology Group Inactivated Probiotics Business Overview
- 4.5.3 Harbin Qiutianhong Health Technology Group Inactivated Probiotics Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Harbin Qiutianhong Health Technology Group Product Portfolio
- 4.5.5 Harbin Qiutianhong Health Technology Group Recent Developments
- 4.6 Probioway
- 4.6.1 Probioway Inactivated Probiotics Company Information
- 4.6.2 Probioway Inactivated Probiotics Business Overview
- 4.6.3 Probioway Inactivated Probiotics Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Probioway Product Portfolio
- 4.6.5 Probioway Recent Developments
- 4.7 Lesaffre
- 4.7.1 Lesaffre Inactivated Probiotics Company Information
- 4.7.2 Lesaffre Inactivated Probiotics Business Overview
- 4.7.3 Lesaffre Inactivated Probiotics Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Lesaffre Product Portfolio
- 4.7.5 Lesaffre Recent Developments
- 4.8 Lallemand Health Solutions
- 4.8.1 Lallemand Health Solutions Inactivated Probiotics Company Information
- 4.8.2 Lallemand Health Solutions Inactivated Probiotics Business Overview
- 4.8.3 Lallemand Health Solutions Inactivated Probiotics Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Lallemand Health Solutions Product Portfolio
- 4.8.5 Lallemand Health Solutions Recent Developments
- 4.9 Glac Biotech
- 4.9.1 Glac Biotech Inactivated Probiotics Company Information
- 4.9.2 Glac Biotech Inactivated Probiotics Business Overview
- 4.9.3 Glac Biotech Inactivated Probiotics Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 Glac Biotech Product Portfolio
- 4.9.5 Glac Biotech Recent Developments
- 4.10 Creative Biolabs
- 4.10.1 Creative Biolabs Inactivated Probiotics Company Information
- 4.10.2 Creative Biolabs Inactivated Probiotics Business Overview
- 4.10.3 Creative Biolabs Inactivated Probiotics Production Capacity, Value and Gross Margin (2021-2026)
- 4.10.4 Creative Biolabs Product Portfolio
- 4.10.5 Creative Biolabs Recent Developments
- 4.11 Chr. Hansen
- 4.11.1 Chr. Hansen Inactivated Probiotics Company Information
- 4.11.2 Chr. Hansen Inactivated Probiotics Business Overview
- 4.11.3 Chr. Hansen Inactivated Probiotics Production Capacity, Value and Gross Margin (2021-2026)
- 4.11.4 Chr. Hansen Product Portfolio
- 4.11.5 Chr. Hansen Recent Developments
- 4.12 Wecare Probiotics
- 4.12.1 Wecare Probiotics Inactivated Probiotics Company Information
- 4.12.2 Wecare Probiotics Inactivated Probiotics Business Overview
- 4.12.3 Wecare Probiotics Inactivated Probiotics Production Capacity, Value and Gross Margin (2021-2026)
- 4.12.4 Wecare Probiotics Product Portfolio
- 4.12.5 Wecare Probiotics Recent Developments
5 Global Inactivated Probiotics Production by Region
- 5.1 Global Inactivated Probiotics Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Inactivated Probiotics Production by Region: 2021-2032
- 5.2.1 Global Inactivated Probiotics Production by Region: 2021-2026
- 5.2.2 Global Inactivated Probiotics Production Forecast by Region (2027-2032)
- 5.3 Global Inactivated Probiotics Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Inactivated Probiotics Production Value by Region: 2021-2032
- 5.4.1 Global Inactivated Probiotics Production Value by Region: 2021-2026
- 5.4.2 Global Inactivated Probiotics Production Value Forecast by Region (2027-2032)
- 5.5 Global Inactivated Probiotics Market Price Analysis by Region (2021-2026)
- 5.6 Global Inactivated Probiotics Production and Value, YOY Growth
- 5.6.1 North America Inactivated Probiotics Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Inactivated Probiotics Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Inactivated Probiotics Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Inactivated Probiotics Production Value Estimates and Forecasts (2021-2032)
6 Global Inactivated Probiotics Consumption by Region
- 6.1 Global Inactivated Probiotics Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Inactivated Probiotics Consumption by Region (2021-2032)
- 6.2.1 Global Inactivated Probiotics Consumption by Region: 2021-2026
- 6.2.2 Global Inactivated Probiotics Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Inactivated Probiotics Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Inactivated Probiotics Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Inactivated Probiotics Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Inactivated Probiotics Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Inactivated Probiotics Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Inactivated Probiotics Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Inactivated Probiotics Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Inactivated Probiotics Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Inactivated Probiotics Production by Type (2021-2032)
- 7.1.1 Global Inactivated Probiotics Production by Type (2021-2032) & (kt)
- 7.1.2 Global Inactivated Probiotics Production Market Share by Type (2021-2032)
- 7.2 Global Inactivated Probiotics Production Value by Type (2021-2032)
- 7.2.1 Global Inactivated Probiotics Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Inactivated Probiotics Production Value Market Share by Type (2021-2032)
- 7.3 Global Inactivated Probiotics Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Inactivated Probiotics Production by Application (2021-2032)
- 8.1.1 Global Inactivated Probiotics Production by Application (2021-2032) & (kt)
- 8.1.2 Global Inactivated Probiotics Production Market Share by Application (2021-2032)
- 8.2 Global Inactivated Probiotics Production Value by Application (2021-2032)
- 8.2.1 Global Inactivated Probiotics Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Inactivated Probiotics Production Value Market Share by Application (2021-2032)
- 8.3 Global Inactivated Probiotics Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Inactivated Probiotics Value Chain Analysis
- 9.1.1 Inactivated Probiotics Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Inactivated Probiotics Production Mode & Process
- 9.2 Inactivated Probiotics Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Inactivated Probiotics Distributors
- 9.2.3 Inactivated Probiotics Customers
10 Global Inactivated Probiotics Analyzing Market Dynamics
- 10.1 Inactivated Probiotics Industry Trends
- 10.2 Inactivated Probiotics Industry Drivers
- 10.3 Inactivated Probiotics Industry Opportunities and Challenges
- 10.4 Inactivated Probiotics Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst